Table 2.1 Asymptomatic Patients Without Known ASCVD
Clinical Scenario Text | ECG Treadmill | Stress Nuclear MPI | Stress Echo | Stress CMR | CAC | CCTA | Cath | No Test | |
|---|---|---|---|---|---|---|---|---|---|
34. | Low ASCVD risk < 5%* | R (2) | R (1) | R (1) | R (1) | M (4) | R (1) | R (1) | A (8) |
35. | Borderline ASCVD risk 5% to 7.5% | M (4) | R (2) | R (2) | R (2) | A (7) | R (2) | R (1) | A (7) |
36. | Borderline ASCVD risk 5% to 7.5% with risk-enhancing factors†| M (4) | R (3) | R (3) | R (3) | A (7) | R (3) | R (1) | A (7) |
37. | Intermediate ASCVD risk 7.5% to 20% with or without risk-enhancing factors†| M (5) | R (3) | R (3) | R (3) | A (8) | R (3) | R (1) | M (5) |
38. | High ASCVD risk > 20% | M (5) | M (4) | M (4) | M (4) | M (6) | M (4) | R (2) | M (5) |